Mayur YC
Mayur YC
SIRAC, Somaiya Vidyavihar University, Mumbai
Verified email at - Homepage
Cited by
Cited by
Nanodrug delivery in reversing multidrug resistance in cancer cells
S Kapse-Mistry, T Govender, R Srivastava, M Yergeri
Frontiers in pharmacology 5, 159, 2014
An overview of tramadol and its usage in pain management and future perspective
M Subedi, S Bajaj, MS Kumar, YC Mayur
Biomedicine & Pharmacotherapy 111, 443-451, 2019
Tumor microenvironment targeted nanotherapy
C Fernandes, D Suares, MC Yergeri
Frontiers in pharmacology 9, 1230, 2018
Design of new drug molecules to be used in reversing multidrug resistance in cancer cells
GJ Peters, VVS Rajendra Prasad, C Lemos, NKMYC Sathish
Current cancer drug targets 9 (3), 298-306, 2009
Anti-calmodulin acridone derivatives modulate vinblastine resistance in multidrug resistant (MDR) cancer cells
R Hegde, P Thimmaiah, MC Yerigeri, G Krishnegowda, KN Thimmaiah, ...
European journal of medicinal chemistry 39 (2), 161-177, 2004
Targeting calmodulin in reversing multi drug resistance in cancer cells
YC Mayur, S Jagadeesh, KN Thimmaiah
Mini reviews in medicinal chemistry 6 (12), 1383-1389, 2006
Acridone-pyrimidine hybrids-design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies
M Murahari, KV Prakash, GJ Peters, YC Mayur
European journal of medicinal chemistry 139, 961-981, 2017
Targeting telomerase for its advent in cancer therapeutics
S Bajaj, MS Kumar, GJ Peters, YC Mayur
Medicinal Research Reviews 40 (5), 1871-1919, 2020
Transition metal complexes of a multidentate Schiff base ligand containing pyridine: synthesis, characterization, enzyme inhibitions, antioxidant properties, and molecular …
MCY Ercan Bursa, Fikret Turkan, Kenan Buldurun, Nevin Turan , Abdulmelik ...
Biometals 34 (2), 393-406, 2021
Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors
YCM Manikanta Murahari, Vivek Mahajan, Sreenivasulu Neeladri, Maushmi S. Kumar
Bioorganic Chemistry 86, 583-597, 2019
Synthesis of 2‐Fluoro N10‐Substituted Acridones and Their Cytotoxicity Studies in Sensitive and Resistant Cancer Cell Lines and Their DNA Intercalation Studies
YC Mayur, Zaheeruddin, GJ Peters, C Lemos, I Kathmann, VVSR Prasad
Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2009
Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2, 4-dimethylacridones as anticancer agents
M Murahari, PS Kharkar, N Lonikar, YC Mayur
European journal of medicinal chemistry 130, 154-170, 2017
Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies
VVSR Prasad, GJ Peters, C Lemos, I Kathmann, YC Mayur
European journal of pharmaceutical sciences 43 (4), 217-224, 2011
Drug-DNA Interaction Studies of Acridone-Based Derivatives.
YMC Thimmaiah K, Ugarkar AG, Martis EF, Shaikh MS, Coutinho EC
Nucleosides Nucleotides Nucleic Acids 34 (5), 309-31, 2015
Identification and usage of fluorescent probes as nanoparticle contrast agents in detecting cancer
MS Murahari, MC Yergeri
Current pharmaceutical design 19 (25), 4622-4640, 2013
Synthesis of novel 1, 3-diacetoxy-acridones as cytotoxic agents and their DNA-binding studies
NK Sathish, VVS Rajendra Prasad, NM Raghavendra, SM Shanta Kumar, ...
Scientia Pharmaceutica 77 (1), 19-32, 2009
Sensitization of multidrug resistant (MDR) cancer cells to vinblastine by novel acridones: correlation between anti-calmodulin activity and anti-MDR activity
YC Mayur, T Padma, BH Parimala, KH Chandramouli, S Jagadeesh, ...
Medicinal Chemistry 2 (1), 63-77, 2006
Cancer cell fusion: A potential target to tackle drug-resistant and metastatic cancer cells
C Fernandes, P Prabhu, K Juvale, D Suares, YC Mayur
Drug Discovery Today 24 (9), 1836-1844, 2019
E-drug delivery: A futuristic approach
KS Yadav, S Kapse-Mistry, GJ Peters, YC Mayur
Drug discovery today 24 (4), 1023-1030, 2019
Design, synthesis, modelling studies and biological evaluation of 1, 3, 4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme
S Bajaj, MS Kumar, H Tinwala, YC Mayur
Bioorganic Chemistry 111, 104873, 2021
The system can't perform the operation now. Try again later.
Articles 1–20